Sloning BioTechnology starting feasibility study to improve the efficiency of an enzyme used in molecular diagnostic application
Sloning will use its Slonomics(TM) industrial scale gene synthesis technology to provide a gene library with a full set of ratio-controlled mutants. The successful completion of the study shall enable bioMérieux to identify an enzyme with significantly enhanced characteristics.
"We are very excited about this collaboration. It gives Sloning the opportunity to demonstrate the capabilities of our enabling technology in the field of protein engineering and synthetic biology and in this particular case with a significant commercial impact to our customer." stated Dr. Heinz Schwer, the company CEO.
Organizations
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Weighing
Precise weighing is critical in laboratory and industrial environments. From accurate dosing of chemicals for research experiments to mass production of products, precise weight determination is often the first and most critical step. Modern balances and weighing instruments are sophisticated, offer impressive precision and are resilient to external influences such as temperature and humidity.
Topic world Weighing
Precise weighing is critical in laboratory and industrial environments. From accurate dosing of chemicals for research experiments to mass production of products, precise weight determination is often the first and most critical step. Modern balances and weighing instruments are sophisticated, offer impressive precision and are resilient to external influences such as temperature and humidity.